A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression
Clinical trial NCT05196971 · COMPLETED
Trial details
- NCT number
- NCT05196971
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2022-04-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.